- Home
- OGN vs AB Comparison
OGN vs AB Comparison
Compare OGN & AB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGN
- AB
- Stock Information
- Founded
- OGN 1923
- AB 1987
- Country
- OGN United States
- AB United States
- Employees
- OGN N/A
- AB N/A
- Industry
- OGN Biotechnology: Pharmaceutical Preparations
- AB Investment Managers
- Sector
- OGN Health Care
- AB Finance
- Exchange
- OGN Nasdaq
- AB Nasdaq
- Market Cap
- OGN 4.0B
- AB 4.3B
- IPO Year
- OGN N/A
- AB 1988
- Fundamental
- Price
- OGN $15.89
- AB $39.81
- Analyst Decision
- OGN Hold
- AB Strong Buy
- Analyst Count
- OGN 3
- AB 5
- Target Price
- OGN $21.33
- AB $43.00
- AVG Volume (30 Days)
- OGN 4.3M
- AB 469.2K
- Earning Date
- OGN 02-13-2025
- AB 02-04-2025
- Dividend Yield
- OGN 7.06%
- AB 7.70%
- EPS Growth
- OGN 120.97
- AB 57.32
- EPS
- OGN 5.04
- AB 3.49
- Revenue
- OGN $6,409,000,000.00
- AB $134,096,000.00
- Revenue This Year
- OGN $3.29
- AB N/A
- Revenue Next Year
- OGN $1.93
- AB $6.95
- P/E Ratio
- OGN $3.15
- AB $11.41
- Revenue Growth
- OGN 4.21
- AB N/A
- 52 Week Low
- OGN $13.87
- AB $30.57
- 52 Week High
- OGN $23.10
- AB $40.77
- Technical
- Relative Strength Index (RSI)
- OGN 55.80
- AB 66.34
- Support Level
- OGN $15.52
- AB $35.13
- Resistance Level
- OGN $16.23
- AB $37.77
- Average True Range (ATR)
- OGN 0.53
- AB 1.02
- MACD
- OGN 0.10
- AB 0.26
- Stochastic Oscillator
- OGN 79.22
- AB 82.98
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
About AB AllianceBernstein Holding L.P.
AllianceBernstein provides investment management services to institutional (42% of assets under management), retail (41%), and private (17%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of October 2024, AB had $793 billion in managed assets, composed primarily of fixed-income (37% of AUM) and equity (42%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.